Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q3 2025 Earnings Call Transcript

Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q3 2025 Earnings Call Transcript November 10, 2025

Insight Molecular Diagnostics Inc. misses on earnings expectations. Reported EPS is $-0.34 EPS, expectations were $-0.23.

Operator: Alright, everyone, and welcome, everyone. And thank you for joining us to discuss Insight Molecular Diagnostics third quarter 2025 results. If you have not seen today’s shareholder letter, please visit Insight Molecular Diagnostics Investor Relations page at...